Results

Total Results: 142 records

Showing results for "assessment".
Users also searched for: quality improvement

61. Warfarin And Nsaids V.8 (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin%20and%20NSAIDs%20V.8.pdf
    September 08, 2020 - Warfarin & NSAIDs Warfarin And Oral NSAIDs Is patient on proton pump inhibitor or misoprostol? And Yes No Assess risk and take action if necessary Possible increased risk of bleeding Is patient able to start on appropriate proton pump inhibitor? Yes Start patient on proton pump inhibit…

62. Cql To Cds Hooks Cards 0
    cds.ahrq.gov/sites/default/files/cds/artifact/logic/2023-10/CQL%20to%20CDS%20Hooks%20cards_0.txt
    January 01, 2023 - Mapping of CQL conditions to CDS Hooks cards Condition: NoDDimerNoWells Card: It is recommended to assess the patient's risk for pulmonary embolism (PE) and evaluate D-dimer levels before proceeding with a CTPA order. Use the following link to evaluate the risk. Launch Questionnaire: Yes Condition: NoDDimerWellsLessT…

63. Warfarin And Ssris Graph V. 5 (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin%20and%20SSRIs%20Graph%20V.%205.pdf
    March 11, 2019 - Warfarin and Antidepressants Warfarin Type of Antidepressant Assess risk and take action if necessary Increased GI and non-GI bleeding risk is possible Assess risk and take action if necessary Increased GI and non-GI bl…

64. Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (April 2021) (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention_2.pdf
    April 01, 2021 - structured (i.e., coded) version of the PCE entitled CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment … Inclusions “within the past 6 years” The ACC/AHA recommends assessment of ASCVD risk every 4 – 6 years … Because lipid profile results and smoking status are inputs to ASCVD risk assessment, the CDS Connect … Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment … CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk

65. Statin Use for the Primary Prevention of CVD in Adults: Patient-facing CDS Intervention (April 2021) (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Patient%20Facing%20CDS%20Intervention_Final_1.pdf
    April 01, 2021 - structured (i.e., coded) version of the PCE entitled CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment … supplemented by enabling data collection directly from the patient through an automated form, risk assessment … Inclusions “within the past 6 years” The ACC/AHA recommends assessment of ASCVD risk every 4 – 6 years … Because lipid profile results and smoking status are inputs to ASCVD risk assessment, the CDS Connect … CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk

66. Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Patient%20Facing%20CDS%20Intervention_Final.pdf
    September 01, 2019 - structured (i.e., coded) version of the PCE entitled CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment … supplemented by enabling data collection directly from the patient through an automated form, risk assessment … Inclusions “within the past 6 years” The ACC/AHA recommends assessment of ASCVD risk every 4-6 years … Since lipid profile results and smoking status are inputs to ASCVD risk assessment, the CDS Connect … CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk

67. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/508_2022_CDS_Connect_IG_Statin_CVD_Patient_Facing_final.pdf
    January 01, 2022 - structured (i.e., coded) version of the PCE entitled CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment … supplemented by enabling data collection directly from the patient through an automated form, risk assessment … Concept Definition and/or Rationale Inclusions “Within the past 6 years” The ACC/AHA recommends assessment … Because lipid profile results and smoking status are inputs to ASCVD risk assessment, the CDS Connect … CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk

68. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
    January 01, 2023 - structured (i.e., coded) version of the PCE entitled CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment … supplemented by enabling data collection directly from the patient through an automated form, risk assessment … Concept Definition and/or Rationale Inclusions “Within the past 6 years” The ACC/AHA recommends assessment … Because lipid profile results and smoking status are inputs to ASCVD risk assessment, the CDS Connect … CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk

69. Statintherapyforthepreventionandtreatmentofcvdecqmderived Change Log
    cds.ahrq.gov/sites/default/files/cds/artifact/logic/2024-08/StatinTherapyForThePreventionAndTreatmentOfCVDeCQMDerived_Change_Log.txt
    January 01, 2024 - added Hospice care [Minimum Data Set] - Codes: added Yes (qualifier value) - Codes: added Functional Assessment … added Hospice care [Minimum Data Set] - Codes: added Yes (qualifier value) - Codes: added Functional Assessment

70. CDS Connect Final Report Year 2 (pdf file)
    cds.ahrq.gov/sites/default/files/reports/AHRQ_Final_Report_2018.pdf
    January 01, 2018 - years None 19 CDS Intervention Pain Assessments (lookback of 2 years): Wong-Baker FACES Assessment … (score, interpretation, date) PEG Assessment (question response and total score, interpretation, date … Identifier Names and Codes (LOINC) representative to apply for LOINC code assignments to two pain assessment … MITRE initially hoped to include the published interpretation of pain assessment scores in the CQL … Occupational Factors Impacting Diabetes 2.2.2 CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment

71. CDS Connect Pilot Final Report Factors to Consider in Managing Chronic Pain: A Pain Management Summary (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/CDSConnectPilotFinalReport508gel10012018.pdf
    September 01, 2018 - provided both qualitative and quantitative information and data to inform ongoing evaluation and outcome assessment … included a description of the research effort, the proposed implementation and evaluation process, and an assessment … She also suggested additional pain assessment tools that measure functional status, such as the American

72. January 2021 CDS Connect Work Group Call (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/1251/CDS_Connect_WG_Jan2021_Slides.pdf
    January 01, 2021 - Screening for Abnormal Blood Glucose Part 1 Screening for abnormal blood glucose as part of CVD risk assessment

73. CDS Connect Work Group meeting - May 2021 (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/2246/CDS_Connect_WG_May%202021_presentation.pdf
    May 01, 2021 - or VSs • Clinical concept representation ► Add or replace VS and code references − Based on prior assessment

74. Warfarin-Nsaids Mdia Implementation Guide (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin-NSAIDs%20MDIA%20Implementation%20Guide.docx
    November 11, 2019 - Implementation Guide Warfarin - NSAIDs Prepared by: Eric Chou Under funding from AHRQ grants R21 HS023826 and R01 HS025984 MDIA publication No. 001 November 11, 2019 Disclaimer The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessarily represen…

75. March 2022 CDS Connect Work Group Presentation (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/71451/CDS_Connect_WG_March_2022_Presentation.pdf
    January 01, 2022 - patients − Not considering CVD risk factors in who it screens nor screening ”as part of a CV risk assessment

76. CDS Connect Implementation Guide Draft (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_USPSTF%20Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_Final.docx
    October 01, 2017 - Patient self-care/family caregivers can use the artifact as part of self-assessment or health maintenance … Delta runs an overall general health self-assessment or cardiac risk self-screen as part of a self-care … RSAs can be compiled into a list and presented immediately with the assessment results, or can be delivered … Provide a notification when the patient has not had an updated ASCVD risk score assessment in the last … back of 6 years for ASCVD risk as a qualifier to ensure clinical relevance The ACC/AHA recommends assessment

77. CDS Connect Work Group meeting - April 2021 (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/1266/CDS_Connect_April2021_WG_Meeting_Slides.pdf
    April 01, 2021 - Resources, and Iris Creative directory • British Medical Journal’s GRADE (Grading of Recommendations, Assessment

78. CDS Connect Work Group Meeting Summary - August 2021 (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/28166/CDS_Connect_WG_Summary_August%202021.pdf
    August 19, 2021 - Guides and CQL logic for four artifacts: • CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment

79. Pain Management Summary Clincial Decision Support Toolkit For Repository (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository.xlsx
    January 01, 2003 - 1 Problem List: contains qualifying chronic pain diagnosis (active) and depression (active) Pain Assessment … opioid medication (active) Problem List: Anxiety (active) and Sleep-disordered breathing (active) Pain Assessment … medication (active) Problem List: renal dysfunction (active) and hepatic dysfunction (active) Pain Assessment … opioid medication (discontinued more than 2 years ago) and naloxone medication (discontinued) Pain Assessment … more than 2 years in the past) and stool softener (discontinued more than 6 months in the past) Pain Assessment

80. Pain Management Summary Clincial Decision Support Toolkit For Repository 0 (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository_0.xlsx
    January 01, 2003 - 1 Problem List: contains qualifying chronic pain diagnosis (active) and depression (active) Pain Assessment … opioid medication (active) Problem List: Anxiety (active) and Sleep-disordered breathing (active) Pain Assessment … medication (active) Problem List: renal dysfunction (active) and hepatic dysfunction (active) Pain Assessment … opioid medication (discontinued more than 2 years ago) and naloxone medication (discontinued) Pain Assessment … more than 2 years in the past) and stool softener (discontinued more than 6 months in the past) Pain Assessment